Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

4.0K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
4.0K
Other Pulmonary Disorders01:17

Other Pulmonary Disorders

1.8K
Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
1.8K
Chronic Obstructive Pulmonary Disease II: Emphysema01:23

Chronic Obstructive Pulmonary Disease II: Emphysema

48
Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
48
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

5.0K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
5.0K
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

40
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
40
Type IV Collagen of Basal Lamina01:05

Type IV Collagen of Basal Lamina

2.5K
Type IV collagen is a 400 nm long, network-forming collagen that acts as a barrier between the epithelial and endothelial cells. Type IV collagen  forms the backbone of the basement membrane by scaffolding with laminin, entactin, proteoglycans, and fibronectin. Apart from rendering structural support to the basement membrane, it also helps entail signaling potentials necessary for both pathological and physiological functions.
A type IV collagen molecule has six alpha chains which can...
2.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pembrolizumab KEYNOTE-001: an adaptive study leading to accelerated approval for two indications and a companion diagnostic.

Annals of oncology : official journal of the European Society for Medical Oncology·2018
Same author

The quality of psychiatric residency : the assessment of programs and options for distributing psychiatric residents in the service of health care reform.

Academic psychiatry : the journal of the American Association of Directors of Psychiatric Residency Training and the Association for Academic Psychiatry·2014
Same author

Phase I/IIa trial of the mammalian target of rapamycin inhibitor ridaforolimus (AP23573; MK-8669) administered orally in patients with refractory or advanced malignancies and sarcoma.

Annals of oncology : official journal of the European Society for Medical Oncology·2012
Same author

Clinical Diagnosis of Intestinal Tuberculosis.

The Yale journal of biology and medicine·2011
Same author

Optimal modeling for phase I design of a two drug combination-results of a phase I study of cisplatin with 9-nitrocamptothecin.

Investigational new drugs·2008
Same author

Post-acute dispositions of older adults hospitalized for depression.

Aging & mental health·2006
Same journal

[Diffuse interstitial fibrosis. Clinico-pathological case].

Revista mexicana de tuberculosis y enfermedades del aparato respiratorio·2014
Same journal

[Mesothelioma of the pericardium. Report of a case].

Revista mexicana de tuberculosis y enfermedades del aparato respiratorio·2014
Same journal

[Pneumonectomy. Analysis of 100 cases].

Revista mexicana de tuberculosis y enfermedades del aparato respiratorio·2014
Same journal

[The physician and social security].

Revista mexicana de tuberculosis y enfermedades del aparato respiratorio·2014
Same journal

[Pulmonary decortication in the treatment of empyema].

Revista mexicana de tuberculosis y enfermedades del aparato respiratorio·2014
Same journal

[Cultivation of Mycobacterium tuberculosis. Comparison of isolation with sodium hydroxide and trisodium phosphate].

Revista mexicana de tuberculosis y enfermedades del aparato respiratorio·2014
See all related articles

Related Experiment Video

Updated: May 2, 2026

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
04:44

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on: June 16, 2020

22.1K

[Collagen diseases which affect the lungs]

E H RUBIN

    Revista Mexicana De Tuberculosis Y Enfermedades Del Aparato Respiratorio
    |February 19, 2014
    PubMed
    Summary

    No abstract available in PubMed .

    Keywords:
    COLLAGEN DISEASESLUNG DISEASES

    More Related Videos

    Author Spotlight: Analyzing Fibrosis Development in Chronic Lung Allograft Rejection Using Picrosirius Red Staining in Mouse Models
    04:42

    Author Spotlight: Analyzing Fibrosis Development in Chronic Lung Allograft Rejection Using Picrosirius Red Staining in Mouse Models

    Published on: March 21, 2025

    1.6K
    Implantation of Fibrin Gel on Mouse Lung to Study Lung-specific Angiogenesis
    07:52

    Implantation of Fibrin Gel on Mouse Lung to Study Lung-specific Angiogenesis

    Published on: December 21, 2014

    9.5K

    Related Experiment Videos

    Last Updated: May 2, 2026

    Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
    04:44

    Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

    Published on: June 16, 2020

    22.1K
    Author Spotlight: Analyzing Fibrosis Development in Chronic Lung Allograft Rejection Using Picrosirius Red Staining in Mouse Models
    04:42

    Author Spotlight: Analyzing Fibrosis Development in Chronic Lung Allograft Rejection Using Picrosirius Red Staining in Mouse Models

    Published on: March 21, 2025

    1.6K
    Implantation of Fibrin Gel on Mouse Lung to Study Lung-specific Angiogenesis
    07:52

    Implantation of Fibrin Gel on Mouse Lung to Study Lung-specific Angiogenesis

    Published on: December 21, 2014

    9.5K